GlaxoSmithKline recalls its heartburn drug Zantac WORLDWIDE amid fears it may contain a cancer-causing chemical – but it’s still available in the US and the UK

Pharmaceutical giant GlaxoSmithKline has recalled all of its Zantac products across the world amid fears they may be unsafe.

The pills may contain traces of NDMA, or N-nitrosodimethylamine, a chemical that is believed to be ‘probably carcinogenic’ to humans.

GSK has already pulled its common heartburn drug from shelves in Ireland, India and Hong Kong in separate moves as far back as two weeks ago.

Read more of the original article from DailyMail